Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...(ues 2006 Revenues amounts) Rev...)

amounts)

Revenues

Analytical Technologies $1,167.1 44.5% $849.0 50.9%

Laboratory Products and Services 1,545.5 59.0% 860.8 51.6%

Eliminations (91.5) -3.5% (40.9) -2.5%

Consolidated Revenues $2,621.1 100.0% $1,668.9 100.0%

Operating Income and Operating Margin

Analytical Technologies $245.1 21.0% $153.8 18.1%

Laboratory Products and Services 207.0 13.4% 109.5 12.7%

Subtotal Reportable Segments 452.1 17.2% 263.3 15.8%

Cost of Revenues Charges (c) (1.2) 0.0% (74.4) -4.5%

Restructuring and Other Costs, Net

(d) (17.7) -0.7% (32.1) -1.9%

Equity Compensation Acceleration

Charges (e) - 0.0% (36.7) -2.2%

Amortization of Acquisition-related

Intangible Assets (148.2) -5.6% (93.2) -5.6%

GAAP Operating Income (a) $285.0 10.9% $26.9 1.6%

Pro Forma Data (unaudited) (k) Three Months Ended (In millions except percentage amounts) December 31, % of

2006 Revenues

Pro Forma Revenues (k)

Analytical Technologies $1,023.6 43.6%

Laboratory Products and Services 1,401.7 59.7%

Eliminations (77.5) -3.3%

Pro Forma Combined Revenues 2,347.8 100.0%

Pre-merger Fisher Scientific

Results, Net of Eliminations (678.9)

GAAP Consolidated Revenues (a) $1,668.9

Pro Forma Operating Inc
'/>"/>